U.S. Markets closed

Advanced Medical Isotope Corporation (ADMD)


Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.075-0.00 (-5.06%)
At close: 3:47PM EDT
People also watch
PPCHHJOEPSIDAMBSVOIS

Advanced Medical Isotope Corporation

1021 North Kellogg Street
Kennewick, WA 99336
United States
509-736-4000
http://www.isotopeworld.com

Sector
Industry
Full Time Employees3

Key Executives

NameTitlePayExercisedAge
Dr. Carlton M. Cadwell D.D.S.Chairman and Sec.N/AN/A72
Dr. Michael K. Korenko Ph.D.Interim Chief Exec. Officer and Interim PresN/AN/A71
Mr. James C. KatzaroffCo-Founder and Director250kN/A60
Mr. Leonard Bruce JolliffChief Financial Officer180kN/A67
Dr. Nigel R. Stevenson Ph.D.Chief Science Officer and Member of Scientific Advisory CommitteeN/AN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Advanced Medical Isotope Corporation, a radiation oncology focused medical device company, develops brachytherapy devices for the treatment of non-resectable tumors. Its brachytherapy products include yttrium-90 RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals. The company serves government and commercial customers in the medical and veterinary sectors. Advanced Medical Isotope Corporation was incorporated in 1994 is headquartered in Kennewick, Washington.

Corporate Governance

Advanced Medical Isotope Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.